Alignment Healthcare, Inc.ALHC
ASignal's systematic analysis rates ALHC as Neutral.
Reflects the latest available analysis · analyzed Aug 24, 2026
The case on ALHC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (31.6% YoY)
- Exceptional earnings growth (142.9% YoY)
- High return on equity (20.04%)
- Free cash flow positive ($188.58M)
- Low enterprise value to revenue (0.52x)
- Cash-rich balance sheet with $701.71M cash vs $330.50M debt
- High P/E ratio (71.27x)
- Low net and operating margins (0.89%, 3.15%)
- MACD below signal line and negative histogram
- Price below 50-day SMA (bearish trend)
- No Reddit retail sentiment data
See the full verdict on ALHC
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ALHC
Most investors never get a second opinion, let alone several. ASignal runs ALHC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.